130 related articles for article (PubMed ID: 38050673)
21. Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation.
Darmoul D; Lacasa M; Baricault L; Marguet D; Sapin C; Trotot P; Barbat A; Trugnan G
J Biol Chem; 1992 Mar; 267(7):4824-33. PubMed ID: 1347043
[TBL] [Abstract][Full Text] [Related]
22. Molecular design of near-infrared (NIR) fluorescent probes targeting exopeptidase and application for detection of dipeptidyl peptidase 4 (DPP-4) activity.
Hoshino Y; Hanaoka K; Sakamoto K; Yasunaga M; Kojima T; Kotani D; Nomoto A; Sasaki E; Komatsu T; Ueno T; Takamaru H; Saito Y; Seto Y; Urano Y
RSC Chem Biol; 2022 Jul; 3(7):859-867. PubMed ID: 35866167
[TBL] [Abstract][Full Text] [Related]
23. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.
Ruiz P; Zacharievich N; Shenkin M
Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992
[TBL] [Abstract][Full Text] [Related]
24. Dipeptidyl peptidase IV (DPP IV/CD26) staining predicts distant metastasis of 'benign' thyroid tumor.
Hirai K; Kotani T; Aratake Y; Ohtaki S; Kuma K
Pathol Int; 1999 Mar; 49(3):264-5. PubMed ID: 10338085
[TBL] [Abstract][Full Text] [Related]
25. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
26. Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV.
Mizushima T; Ohnishi S; Shimizu Y; Hatanaka Y; Hatanaka KC; Kuriki Y; Kamiya M; Homma A; Yamamoto K; Ono S; Urano Y; Sakamoto N
Head Neck; 2018 Jul; 40(7):1466-1475. PubMed ID: 29509281
[TBL] [Abstract][Full Text] [Related]
27. Detection of dipeptidyl peptidase IV in glioma C6 and neuroblastoma SK-N-SH cell lines.
Sedo A; Revoltella RP
Biochem Cell Biol; 1995; 73(1-2):113-5. PubMed ID: 7662310
[TBL] [Abstract][Full Text] [Related]
28. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
Juillerat-Jeanneret L
J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
[TBL] [Abstract][Full Text] [Related]
29. Bestatin and bacitracin inhibit porcine kidney cortex dipeptidyl peptidase IV activity and reduce human melanoma MeWo cell viability.
Méndez LR; Arrebola Y; Valdés-Tresanco ME; Díaz-Guevara L; Bergado G; Sánchez B; Charli JL; Pascual Alonso I
Int J Biol Macromol; 2020 Dec; 164():2944-2952. PubMed ID: 32846184
[TBL] [Abstract][Full Text] [Related]
30. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
[TBL] [Abstract][Full Text] [Related]
31. Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes.
Flatt PR; Bailey CJ; Green BD
Front Biosci; 2008 May; 13():3648-60. PubMed ID: 18508462
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the susceptibility of porcine and human dipeptidyl-peptidase IV to inhibition by protein-derived peptides.
Lacroix IM; Li-Chan EC
Peptides; 2015 Jul; 69():19-25. PubMed ID: 25828735
[TBL] [Abstract][Full Text] [Related]
33. Optimization of gold nanoparticle-based real-time colorimetric assay of dipeptidyl peptidase IV activity.
Aldewachi HS; Woodroofe N; Turega S; Gardiner PHE
Talanta; 2017 Jul; 169():13-19. PubMed ID: 28411801
[TBL] [Abstract][Full Text] [Related]
34. Features of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from dietary proteins.
Nongonierma AB; FitzGerald RJ
J Food Biochem; 2019 Jan; 43(1):e12451. PubMed ID: 31353485
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (Part II): in silico prediction in antidiabetic extracts.
Guasch L; Sala E; Ojeda MJ; Valls C; Bladé C; Mulero M; Blay M; Ardévol A; Garcia-Vallvé S; Pujadas G
PLoS One; 2012; 7(9):e44972. PubMed ID: 23028712
[TBL] [Abstract][Full Text] [Related]
36. FosB recruits KAT5 to potentiate the growth and metastasis of papillary thyroid cancer in a DPP4-dependent manner.
Du J; Fu L; Ji F; Wang C; Liu S; Qiu X
Life Sci; 2020 Oct; 259():118374. PubMed ID: 32891613
[TBL] [Abstract][Full Text] [Related]
37. Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.
Sauvé M; Ban K; Momen MA; Zhou YQ; Henkelman RM; Husain M; Drucker DJ
Diabetes; 2010 Apr; 59(4):1063-73. PubMed ID: 20097729
[TBL] [Abstract][Full Text] [Related]
38. Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model.
Davis JA; Kumar PS; Singh S; Surender A; Roy S; Khanna V; Sethi S; Pal C; Sharma L; Benjamin B; Mittra S; Sattigeri J; Bansal VS
Indian J Pharmacol; 2012; 44(6):759-64. PubMed ID: 23248408
[TBL] [Abstract][Full Text] [Related]
39. Multivalent dipeptidyl peptidase IV fragment-nanogold complex inhibits cancer metastasis by blocking pericellular fibronectin.
Yang ML; Huang YJ; Lin YC; Lin YH; Hung TT; Shiau AL; Cheng HC; Wu CL
Biomater Adv; 2023 May; 148():213357. PubMed ID: 36871348
[TBL] [Abstract][Full Text] [Related]
40. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
